US4668670A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Tin diiododeuteroporphyrin and therapeutic use thereof
Assignee: Rockefeller University
•
Filing: 1986-06-20
•
Granted: 1987-05-26
•
Expires: 2006-06-20
Abstract
Abstract Use of the novel compound tin diiododeuteroporphyrin and compositions containing it to inhibit heme mebabolism in mammals, to control the rate of tryptophan metabolism in mammals, and to increase the rate at which heme and iron are excreted by mammals.
Inventors
- 👤 Darryl Rideout
- 👤 Attallah Kappas
- 👤 George S. Drummond
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 07:37
CPC Classifications
C; C07; C07F; C07F7/00; C07F7/22; C07F7/2204; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
2 words
Tin diiododeuteroporphyrin.
Claim 2
Dependent Claim
2 words
Tin diiododeuteroporphyrin.
Claim 3
Dependent Claim
13 words
A pharmaceutical composition for parenteral administration comprising tin diiododeuteroporphyrin and pharmaceutically acceptable carrier.
Claim 4
Dependent Claim
13 words
A pharmaceutical composition for parenteral administration comprising tin diiododeuteroporphyrin and pharmaceutically acceptable carrier.
Claim 5
Dependent Claim
27 words
A pharmaceutical composition in dosage unit form for parenteral administration comprising tin diiododeuteroporphyrin at a concentration of 0.5 μmol/ml to 25 μmol/ml in a pharmaceutically acceptable carrier.
Claim 6
Dependent Claim
27 words
A pharmaceutical composition in dosage unit form for parenteral administration comprising tin diiododeuteroporphyrin at a concentration of 0.5 μmol/ml to 25 μmol/ml in a pharmaceutically acceptable carrier.
Claim 7
Independent Claim
34 words
A method of decreasing the rate of metabolism of heme in mammals in need of such treatment by administering to the mammal an amount of tin diiododeuteroporphyrin which is effective to decrease said rate.
Claim 8
Independent Claim
34 words
A method of decreasing the rate of metabolism of heme in mammals in need of such treatment by administering to the mammal an amount of tin diiododeuteroporphyrin which is effective to decrease said rate.
Claim 9
Dependent Claim
12 words
A method as in claim 4 wherein the mammal is a human.
References Cited (Backward Citations)
WO1983000287A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-05-25 | 1990-11-24 | 1991-05-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-05-25 | 1994-11-24 | 1995-05-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-05-25 | 1998-11-24 | 1999-05-26 | $7700.00 | Window Closed / Lapsed |